Farrowsure®
Farrowsure®
Farrowsure® GOLD / Farrowsure® GOLD B
Parovirus Vaccine killed virus Erysipelothrix rhusiopathiae-leptospira cancola-grippotyphosa-hardjo-loterohaemorrhagiae-pomona bacterin
When protecting sows and gilts from costly breeding herd diseases — parvovirus, leptospirosis and erysipelas — you can count on Farrowsure® GOLD and Farrowsure® GOLD B to help ensure healthy pigs.
Indications
- Farrowsure® GOLD and Farrowsure® GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona.
- Farrowsure GOLD B helps protect against L. bratislava.
How It Works
How It Work
Farrowsure® GOLD and Farrowsure® GOLD B help protect against some of the leading causes of reproductive failure in swine — parvovirus, leptospirosis and erysipelas – which are costly breeding herd diseases.
Farrowsure GOLD and Farrowsure GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. Farrowsure GOLD B helps protect against L. bratislava.
Farrowsure® GOLD and Farrowsure® GOLD B contain two adjuvants, including Amphigen®, which enhances the immune response using the animal’s natural defense system to fight disease.
- Farrowsure GOLD and Farrowsure GOLD B provide clinically demonstrated 18-week post-vaccination duration of immunity against erysipelas caused by Erysipelothrix rhusiopathiae.1
- Three field safety studies involving 205 prebreeding gilts and 406 gestating sows and gilts indicated that two doses of Farrowsure GOLD B, in combination with FluSure XP®, can be safely administered to prebreeding gilts and that a dose can be safely given to pregnant sows as late as two to four weeks prior to farrowing (73 to 101 days of gestation).2-4
- In a field safety study conducted in prebreeding gilts, injection site reactions were rare.3
- Results were similar in gestating sows and gilts: When administered according to label directions to pregnant sows and gilts at two to four weeks prior to farrowing, reactions were minimal in number, of little consequence in severity and transient in duration.2,3
Shake well. Aseptically administer 2 mL intramuscularly.
Healthy swine should receive two doses three to five weeks apart, with the second dose administered two to four weeks prior to breeding. Healthy gilts, however, should receive the second dose as near as possible to 14 days prior to breeding.
Revaccination with a single dose is recommended prior to subsequent breedings. Boars should be revaccinated semiannually.
Farrowsure® GOLD protects sows and gilts from costly breeding-herd diseases like parvovirus, leptospirosis and erysipelas. Farrowsure GOLD and Farrowsure® GOLD B are approved for use in healthy breeding swine as an aid in preventing reproductive failure caused by porcine parvovirus (PPV); erysipelas caused by Erysipelothrix rhusiopathiae; and leptospirosis caused by Leptospira canicola, L. grippotyphosa, L. hardjo, L. icterohaemorrhagiae and L. pomona. Farrowsure GOLD B helps protect against L. bratislava.
- Safety Information
- Do not vaccinate within 21 days before slaughter.
- Contains gentamicin as a preservative.
- Transient injection-site swelling and/or inappetence may occur following vaccination.
- As with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.
- This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.
Storage and handling
- Store at 2° C to 7° C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.
- Use entire contents when first opened.
- Sterilized syringes and needles should be used to administer this vaccine.
Whilst every effort has been made to provide the correct information on these product sheets, some of the information may not be correct. Please check the original label prior to any application of the product.
View Next
- Poultry
